PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32898790-4 2020 This method enabled the challenging radiosynthesis of [11C]nor-buprenorphine ([11C]nor-BUP), the main metabolite of buprenorphine (BUP) which has been identified as a substrate of the P-glycoprotein (P-gp) transport function at the blood-brain barrier (BBB). Buprenorphine 63-76 ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus 184-198 32898790-4 2020 This method enabled the challenging radiosynthesis of [11C]nor-buprenorphine ([11C]nor-BUP), the main metabolite of buprenorphine (BUP) which has been identified as a substrate of the P-glycoprotein (P-gp) transport function at the blood-brain barrier (BBB). Buprenorphine 63-76 ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus 200-204 32898790-4 2020 This method enabled the challenging radiosynthesis of [11C]nor-buprenorphine ([11C]nor-BUP), the main metabolite of buprenorphine (BUP) which has been identified as a substrate of the P-glycoprotein (P-gp) transport function at the blood-brain barrier (BBB). Buprenorphine 87-90 ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus 184-198 32898790-4 2020 This method enabled the challenging radiosynthesis of [11C]nor-buprenorphine ([11C]nor-BUP), the main metabolite of buprenorphine (BUP) which has been identified as a substrate of the P-glycoprotein (P-gp) transport function at the blood-brain barrier (BBB). Buprenorphine 87-90 ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus 200-204 17365275-0 2007 P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier. Buprenorphine 59-72 ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus 0-14 17365275-1 2007 The involvement of P-glycoprotein (P-gp) in buprenorphine (BNP) transport at the blood-brain barrier (BBB) in rats was investigated in vivo by means of both the brain uptake index technique and the brain efflux index technique. Buprenorphine 44-57 ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus 19-33 17365275-1 2007 The involvement of P-glycoprotein (P-gp) in buprenorphine (BNP) transport at the blood-brain barrier (BBB) in rats was investigated in vivo by means of both the brain uptake index technique and the brain efflux index technique. Buprenorphine 44-57 ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus 35-39 17365275-1 2007 The involvement of P-glycoprotein (P-gp) in buprenorphine (BNP) transport at the blood-brain barrier (BBB) in rats was investigated in vivo by means of both the brain uptake index technique and the brain efflux index technique. Buprenorphine 59-62 ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus 19-33 17365275-1 2007 The involvement of P-glycoprotein (P-gp) in buprenorphine (BNP) transport at the blood-brain barrier (BBB) in rats was investigated in vivo by means of both the brain uptake index technique and the brain efflux index technique. Buprenorphine 59-62 ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus 35-39 17365275-3 2007 The increment of the BNP uptake by the brain suggests the involvement of a P-gp efflux mechanism of BNP transport at the BBB. Buprenorphine 21-24 ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus 75-79 17365275-3 2007 The increment of the BNP uptake by the brain suggests the involvement of a P-gp efflux mechanism of BNP transport at the BBB. Buprenorphine 100-103 ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus 75-79